Omnipaque
Adolescent Obesity
University of Colorado, DenverPhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Adolescent Obesity cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Rybelsus Pfizer | Phase 2/3 | BB |
AMINO ACIDS,ESSENTIAL University of Colorado, Denver | Phase 3 | B |
DEXTRAN 40 FOR INJECTION University of Colorado, Denver | D | |
GLUCOSE, ANHYDROUS The Rogosin Institute | N/A | D |
Same molecule, other indications
Omnipaque is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →